Browse All

Current Filters

CLEAR FILTER x

TITLE

Beyond The Headache: Atypical Peripartum Reversible Cerebral Vasoconstriction Syndrome

Author:Gaston, Twila   John, Rebecca   Benesh, Frank   

Session Name:P1: Cerebrovascular Disease and Interventional Neurology: Stroke Secondary to Vasculopathy or Thrombosis  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P1.007  

Author Institution:University of Alabama at Birmingham Medical Center, Birmingham, AL  University of Alabama Hospital, Birmingham, AL  University of Alabama At Birmingham, Birmingham, AL  

Identification of Functional Impairment in Individuals with Huntington’s Disease Chorea: A Modified Delphi Consensus Study

Author:Klepitskaya, Olga   Seeberger, Lauren   Fiano, Ryan   Hikmat, Zade   Hinton, Sean   Liu, Emily   Necas, Katherine   Nedzesky, Justin   Serbin, Michael   Tapp, Dwight   Sung, Victor   

Session Name:P2: Movement Disorders: Hyperkinetic Movement Disorders 1  

Topic:Movement Disorders  

Program Number:P2.011  

Author Institution:Neurocrine Biosciences, Inc., San Diego, CA  Boise VA Medical Center, Eagle, ID  Cencora, PA  Neurocrine Biosciences Inc., Frisco, TX  University of Alabama At Birmingham, Birmingham, AL  

Foslevodopa/Foscarbidopa Reduces Troublesome Dyskinesia in People with Advanced Parkinson’s Disease in Two Phase Three Clinical Trials

Author:Hauser, Robert   Antonini, Angelo   Garbin Di Luca, Daniel   Freire Alvarez, Eric   Oliveira Fernandes, Michelle   Shah, Megha   Bergmann, Lars   Gupta, Resmi   O'Meara, Marie   Standaert, David   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.011  

Author Institution:University of South Florida Parkinson’s Disease and Movement Disorders Center of Excellence, Tampa, FL  University of Padova, Italy  Washington University in St. Louis, St. Louis, MO  Hospital General Universitario of Elche, Elche, Spain  AbbVie Inc., Mettawa, IL  University of Alabama At Birmingham, Birmingham, AL  

MG-ADL Subdomain Score Changes With Eculizumab or Ravulizumab: An Analysis of the Global MG SPOTLIGHT Registry

Author:Juel, Vern   Macwan, Samir   Sacca, Francesco   Gordon, Andrew   Zeinali, Lida   Winkley, James   Liu, Chuang   Cutter, Gary   Dodig, Dubravka   Alpers, Joshua   Tandan, Rup   

Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P4.008  

Author Institution:Duke University, Durham, NC  Eisenhower Health Center, Rancho Mirage, CA  University of Naples Federico II, Napoli, Italy  Northwest Neurology, Ltd., Lake Barrington, IL  Alexion, AstraZeneca Rare Disease, Mississauga, ON, Canada  Baptist Health Medical Group Neurology, Lexington, KY  Alexion, AstraZeneca Rare Disease, Baar, Switzerland  University of Alabama At Birmingham, Birmingham, AL  University of Toronto/Toronto Western Hospital, Toronto, ON, Canada  Erlanger Medical Center, Chattanooga, TN  University of Vermont Medical Center, Burlington, VT  

Optimizing Post-stroke Continuity of Care: Insights from Three Models of Outpatient Follow-up

Author:Donovan, Kelliann   Esensoy, Turkan   Parker, Carolina   Nguyen, Michelle   Bahna, Samar   Gropen, Toby   Lyerly, Michael   

Session Name:P5: Cerebrovascular Disease and Interventional Neurology: Stroke Treatment, Outcomes, and Rehabilitation Strategies 2  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P5.017  

Author Institution:University of Alabama At Birmingham, Birmingham, AL  University of Oregon, Portland, OR